Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
Publish Date: 2026-07-16 08:16:00
Source Domain: www.prnewswire.com
- Helio Genomics appoints Parminder “Parry” Bhatia, former Senior Vice President of Artificial Intelligence at Edwards Lifesciences, to its Board of Directors.
- Parry Bhatia has extensive experience in AI deployment in regulated healthcare environments, previously serving as Chief AI Officer at GE HealthCare.
- He has held AI and machine learning roles at Amazon and Microsoft, and also contributed to AI initiatives at Georgia Tech.
- Helio Genomics, an AI-powered precision liver diagnostics company, aims to improve cancer detection and outcomes through early intervention and precision medicine.
- The appointment aims to leverage Parry Bhatia’s expertise to advance Helio Genomics’ AI-driven platform and support its mission of early cancer detection.
